Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients

OBJECTIVE: Multiple myeloma is a heterogeneous disorder and the intratumor genetic heterogeneity contributes to emergency of drug resistance. Dexamethasone has been used clinically for decades for MM. Nevertheless, their use is severely hampered by the risk of developing side effects and the occurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yuyue, Liu, Yijun, He, Wanting, Zhao, Weiwei, Pan, Jiaqi, Gao, Haiyan, Li, Yuying, Zhang, Ying, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320976/
https://www.ncbi.nlm.nih.gov/pubmed/37407915
http://dx.doi.org/10.1186/s12885-023-11084-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320976/
https://www.ncbi.nlm.nih.gov/pubmed/37407915
http://dx.doi.org/10.1186/s12885-023-11084-x

Ejemplares similares